Mass Production of Highly Active NK Cells for Cancer Immunotherapy in a GMP Conform Perfusion Bioreactor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mass Production of Highly Active NK Cells for Cancer Immunotherapy in a GMP Conform Perfusion Bioreactor

Published:2019-08-13 Issue: Volume:7 Page:
ISSN:2296-4185
Container-title:Frontiers in Bioengineering and Biotechnology
language:
Short-container-title:Front. Bioeng. Biotechnol.

Author:

Bröker Katharina,Sinelnikov Evgeny,Gustavus Dirk,Schumacher Udo,Pörtner Ralf,Hoffmeister Hans,Lüth Stefan,Dammermann Werner

Publisher

Frontiers Media SA

Subject

Biomedical Engineering,Histology,Bioengineering,Biotechnology

Reference74 articles.

1. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice;Arbonés;Immunity,1994

2. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46;Arnon;Blood,2004

3. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma;Belting;Eur. J. Immunol.,2015

4. Dysregulation of chemokine/chemokine receptor axes and NK cell tissue localization during diseases;Bernardini;Front. Immunol.,2016

5. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets;Bernardini;Blood,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review and statistical analysis to identify and describe relationships between CQAs and CPPs of natural killer cell expansion processes;Cytotherapy;2024-06

2. Enhanced NK cell proliferation by stress-induced feeder cells;2024-02-12

3. A clinically relevant large‐scale biomanufacturing workflow to produce natural killer cells and natural killer cell‐derived extracellular vesicles for cancer immunotherapy;Journal of Extracellular Vesicles;2023-12

4. Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer;Frontiers in Immunology;2023-10-18

5. Process engineering of natural killer cell-based immunotherapy;Trends in Biotechnology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3